Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
1.320
-0.050 (-3.65%)
Feb 21, 2025, 4:00 PM EST - Market closed
Cue Biopharma Employees
Cue Biopharma had 53 employees as of December 31, 2023. The number of employees increased by 1 or 1.92% compared to the previous year.
Employees
53
Change (1Y)
1
Growth (1Y)
1.92%
Revenue / Employee
$179,849
Profits / Employee
-$841,736
Market Cap
83.62M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CUE News
- 3 months ago - Cue Biopharma Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Cue Biopharma to Participate in Fireside Discussion at the Piper Sandler 36th Annual Healthcare Conference - GlobeNewsWire
- 3 months ago - Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 months ago - Cue Biopharma Announces Strategic Organizational Transition - GlobeNewsWire
- 3 months ago - Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting - GlobeNewsWire
- 5 months ago - Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer's (SITC) 39th Annual Meeting - GlobeNewsWire
- 5 months ago - Cue Biopharma Announces Pricing of $12.0 Million Public Offering - GlobeNewsWire
- 5 months ago - Cue Biopharma Announces Proposed Public Offering - GlobeNewsWire